RE:RE:RE:RE:YOY 2020 and 2021The important thing to take away, folks, is what Investor10X is trying to say is that DM is "undervalued". While I appreciate your valid points, swyint123888, don't forget Investor10X knows everything and they are never wrong.
Investor10X wrote: swyint123888 wrote: Yes you can't grow every quarter but considering Q1 is without doubt going to show a slowdown (according to amount of tests performed by scrn) Q4 becomes more important is all......yes I know there is more to Q1 than scrn tests but mark my work Q1 this year will not be 19 million, take that to the bank
I find it interesting that last year with $18 million of the $19 million being covid money the market didn't react well to that amazing amount of revenue because it wasn't AI revenue. Or at least that was the reasons given, by those bashing the stock. This year the AI will be higher and covid may be lower (hard to say) and still people will complain. If AI was the focus last year and not the amount of revenue then Q1 2022 AI will most likely show an increase in growth. As for lower covid testing for Q1 that is very hard to tell. The majority of all the testing in the movie industry may still be PCR.
A company like DM having different verticals in different sectors means you will see a fluctuation of revenue from month to month and quarter to quarter, but overall you hope it all adds up to increased revenue year-over-year.